The impact of the nodal status and resection margin on the effectiveness of adjuvant chemotherapy for pancreatic cancer: It calls for more careful evaluation

Zhen Tan^{1

2

3

4}, Chen Liang^{1

2

3

4}, Xianjun Yu^{1

2

3

4}, Si Shi^{1

2

3

4}

Affiliations

¹ Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
² Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
³ Shanghai Pancreatic Cancer Institute, Shanghai, China.
⁴ Pancreatic Cancer Institute, Fudan University, Shanghai, China.

Comment

Zhen Tan et al. J Surg Oncol. 2019 Nov.

. 2019 Nov;120(6):1053-1054.

doi: 10.1002/jso.25690. Epub 2019 Aug 30.

Zhen Tan^{1

2

3

4}, Chen Liang^{1

2

3

4}, Xianjun Yu^{1

2

3

4}, Si Shi^{1

2

3

4}

¹ Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
² Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
³ Shanghai Pancreatic Cancer Institute, Shanghai, China.
⁴ Pancreatic Cancer Institute, Fudan University, Shanghai, China.

No abstract available

Comment in

Adjuvant chemotherapy and outcomes in patients with nodal and resection margin-negative pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
Flaum N, Hubner RA, Valle JW, Amir E, McNamara MG. Flaum N, et al. J Surg Oncol. 2019 Jun;119(7):932-940. doi: 10.1002/jso.25440. Epub 2019 Mar 5. J Surg Oncol. 2019. PMID: 30838647